Drug Shortage Report for APO-NAPROXEN EC

Last updated on 2018-07-31 History
Report ID 20882
Drug Identification Number 02246701
Brand name APO-NAPROXEN EC TABLETS
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-02
Actual start date 2017-09-22
Estimated end date 2018-08-08
Actual end date 2018-07-30
Shortage status Resolved
Updated date 2018-07-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-07-31 English Compare
v18 2018-07-30 French Compare
v17 2018-07-30 English Compare
v16 2018-05-27 French Compare
v15 2018-05-27 English Compare
v14 2018-05-15 French Compare
v13 2018-05-15 English Compare
v12 2018-04-24 French Compare
v11 2018-04-24 English Compare
v10 2018-03-23 French Compare
v9 2018-03-23 English Compare
v8 2018-01-16 French Compare
v7 2018-01-16 English Compare
v6 2017-10-10 French Compare
v5 2017-10-10 English Compare
v4 2017-09-26 French Compare
v3 2017-09-26 English Compare
v2 2017-09-04 French Compare
v1 2017-09-04 English Compare

Showing 1 to 19 of 19